c-Myc-dependent tumors (adenocarcinomas and non-small lung, breast, and colon cancer) could potentially respond to USP28, USP36, USP37, all DUBs affecting c-Myc protein turnover. This evidence concerns the gene USP37 and malignant colon neoplasm.